We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cvs Group Plc | LSE:CVSG | London | Ordinary Share | GB00B2863827 | ORD 0.2P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 0.10% | 976.00 | 981.00 | 983.00 | 991.00 | 970.00 | 970.00 | 203,450 | 16:35:16 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Veterinary Svcs-animal Specs | 608.3M | 41.9M | 0.5843 | 16.79 | 703.5M |
From Apr 2019 to Apr 2024
TIDMCVSG
RNS Number : 2104O
CVS Group plc
30 September 2019
CVS Group plc
("CVS" or the "Company")
Exercise of Options and Total Voting Rights
CVS, one of the UK's leading providers of integrated veterinary services for small and large animals, confirms that it has issued a total of 509 new ordinary shares of 0.2 pence each ("Ordinary Shares") during September, as a result of the exercise of options by certain employees under the Company's Save As You Earn (SAYE) 2015/2018 scheme (the "SAYE Shares").
The SAYE Shares rank pari passu with all existing Ordinary Shares and admission has been satisfied via the Company's block listing, application for which was announced on 19 December 2018.
Following the above new issuance, the Company has a total issued share capital at the date of this announcement of 70,653,893 Ordinary Shares each carrying one voting right.
The Company does not hold any Ordinary Shares in treasury. The total number of voting rights is therefore 70,653,893. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Contacts:
CVS Group Plc Tel: 01379 644288
Simon Innes, Chief Executive
Richard Fairman, Finance Director
N+1 Singer (Nominated Adviser & Broker) Tel: 0207 496 3000
Aubrey Powell (Corporate Finance)
Rachel Hayes (Corporate Broking)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TVRBUGDCBBXBGCG
(END) Dow Jones Newswires
September 30, 2019 11:14 ET (15:14 GMT)
1 Year Cvs Chart |
1 Month Cvs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
